Reported Standalone quarterly numbers for Balaxi Pharmaceuticals are:Net Sales at Rs 30.35 crore in March 2023 up 47% from Rs. 20.65 crore in March 2022.
Quarterly Net Profit at Rs. 3.94 crore in March 2023 up 11.82% from Rs. 3.53 crore in March 2022.
EBITDA stands at Rs. 5.58 crore in March 2023 up 12.05% from Rs. 4.98 crore in March 2022.
Balaxi Pharma EPS has increased to Rs. 3.90 in March 2023 from Rs. 3.53 in March 2022.
| Balaxi Pharma shares closed at 570.30 on May 26, 2023 (NSE) and has given -0.04% returns over the last 6 months and 47.12% over the last 12 months. |
| Balaxi Pharmaceuticals | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'23 | Dec'22 | Mar'22 | | Net Sales/Income from operations | 30.35 | 23.07 | 20.65 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 30.35 | 23.07 | 20.65 | | EXPENDITURE | | Consumption of Raw Materials | 22.87 | 17.12 | 14.87 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -- | -- | -- | | Power & Fuel | -- | -- | -- | | Employees Cost | 1.24 | 1.31 | 0.78 | | Depreciation | 0.27 | 0.08 | 0.08 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | 0.84 | 1.07 | 1.09 | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | -- | -- | -- | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 5.13 | 3.48 | 3.83 | | Other Income | 0.18 | 1.34 | 1.07 | | P/L Before Int., Excpt. Items & Tax | 5.31 | 4.83 | 4.90 | | Interest | 0.23 | 0.01 | 0.02 | | P/L Before Exceptional Items & Tax | 5.09 | 4.81 | 4.88 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 5.09 | 4.81 | 4.88 | | Tax | 1.14 | 1.28 | 1.35 | | P/L After Tax from Ordinary Activities | 3.94 | 3.53 | 3.53 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 3.94 | 3.53 | 3.53 | | Equity Share Capital | 10.18 | 10.02 | 10.00 | | Reserves Excluding Revaluation Reserves | -- | -- | 47.91 | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 3.90 | 3.52 | 3.53 | | Diluted EPS | 3.83 | 3.44 | 3.53 | | EPS After Extra Ordinary | | Basic EPS | 3.90 | 3.52 | 3.53 | | Diluted EPS | 3.83 | 3.44 | 3.53 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|